We are live on ! Find out more
ARTA

A.R.T. Advisors Portfolio holdings

AUM $1.79M
1-Year Est. Return 57.47%
This Fund
S&P 500
This Quarter Est. Return
+2.65%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
–
AUM
$1.89B
AUM Growth
-$283M
Cap. Flow
-$295M
Cap. Flow %
-15.65%
Top 10 Hldgs %
7.6%
Holding
2,000
New
609
Increased
340
Reduced
399
Closed
638

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$10.9M
2
M icon
Macy's
M
+$10.7M
3
DVN icon
Devon Energy
DVN
+$9.78M
4
DLTR icon
Dollar Tree
DLTR
+$9.62M
5
JNPR
Juniper Networks
JNPR
+$9.19M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$15.4M
2
MU icon
Micron Technology
MU
+$14.7M
3
MRK icon
Merck
MRK
+$13.1M
4
LRCX icon
Lam Research
LRCX
+$13M
5
COF icon
Capital One
COF
+$12.5M

Sector Composition

Rank Sector Weight
1 Industrials 13.55%
2 Technology 13.54%
3 Consumer Discretionary 13.21%
4 Healthcare 12.74%
5 Financials 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NDLS icon
1251
Noodles & Co
NDLS
$90.5M
$104K 0.01%
3,344
-2,538
-43% -$99.1K
CALL
1252
DELISTED
magicJack VocalTec Ltd
CALL
$103K 0.01%
+14,370
New +$110K
FLNA
1253
Filana Therapeutics
FLNA
$43M
$102K 0.01%
24,955
+11,798
+90% +$55.7K
QHC
1254
DELISTED
Quorum Health Corporation
QHC
$100K 0.01%
+24,104
New +$98.9K
LCTX icon
1255
Lineage Cell Therapeutics
LCTX
$257M
$99K 0.01%
+36,215
New +$101K
AGRX
1256
DELISTED
Agile Therapeutics
AGRX
$97K 0.01%
+13
New +$90K
FCEL icon
1257
FuelCell Energy
FCEL
$1.7B
$96K 0.01%
+217
New +$96K
PDLI
1258
DELISTED
PDL BioPharma, Inc.
PDLI
$96K 0.01%
39,109
-331,891
-89% -$763K
SCYX icon
1259
SCYNEXIS
SCYX
$37M
$95K 0.01%
+665
New +$110K
OCRX
1260
DELISTED
Ocera Therapeutics, Inc.
OCRX
$95K 0.01%
+82,397
New +$95.8K
APPS icon
1261
Digital Turbine
APPS
$1.02B
$93K ﹤0.01%
90,998
+58,309
+178% +$61.7K
RLGT icon
1262
Radiant Logistics
RLGT
$416M
$93K ﹤0.01%
17,397
-1,193
-6% -$6.88K
PFNX
1263
DELISTED
Pfenex Inc.
PFNX
$92K ﹤0.01%
+23,176
New +$107K
RIGL icon
1264
Rigel Pharmaceuticals
RIGL
$680M
$90K ﹤0.01%
+3,310
New +$90.6K
SAUC
1265
DELISTED
Diversified Restaurant Holdings, Inc. Common stock
SAUC
$90K ﹤0.01%
34,958
+20,326
+139% +$58K
ACTG icon
1266
Acacia Research
ACTG
$450M
$86K ﹤0.01%
+21,000
New +$97.7K
ADVM
1267
DELISTED
Adverum Biotechnologies
ADVM
$84K ﹤0.01%
3,366
+1,590
+90% +$43.5K
FOMX
1268
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$84K ﹤0.01%
+18,308
New +$81.7K
SB icon
1269
Safe Bulkers
SB
$781M
$83K ﹤0.01%
+36,283
New +$80K
ORN icon
1270
Orion Group Holdings
ORN
$514M
$82K ﹤0.01%
11,013
-13,300
-55% -$99.4K
TPST icon
1271
Tempest Therapeutics
TPST
$14.8M
$82K ﹤0.01%
18
-12
-40% -$50.8K
ALPN
1272
DELISTED
Alpine Immune Sciences Inc
ALPN
$81K ﹤0.01%
8,411
-7,008
-45% -$67.2K
CETX icon
1273
Cemtrex
CETX
$4.65M
– –
0
– –
TNDM icon
1274
Tandem Diabetes Care
TNDM
$1.17B
$79K ﹤0.01%
+9,944
New +$91.9K
NOVN
1275
DELISTED
Novan, Inc. Common Stock
NOVN
$78K ﹤0.01%
1,938
-3,647
-65% -$180K
49 50
51
52 53

Similar funds

MA
MANA Advisors New York $3.06M AUM 7.13% 1-Year Est. Return
FFIM
Founders Fund III Management San Francisco, California $435K AUM
LC
Lunia Capital Dallas, Texas $4.49M AUM 42.82% 1-Year Est. Return
YEPV
Yorktown Energy Partners VI New York $6.21M AUM 74.4% 1-Year Est. Return
AAM
Areion Asset Management Hong Kong $7.82M AUM 16% 1-Year Est. Return
CCM
Copernicus Capital Management San Francisco, California $8.26M AUM 37.91% 1-Year Est. Return
IR
Invictus RG Hamilton, Bermuda $8.9M AUM 56.32% 1-Year Est. Return
IFC
Intact Financial Corporation Toronto, Ontario, Canada $14M AUM

A.R.T. Advisors's Q2 2017 Portfolio in Review

As of Q2 2017, A.R.T. Advisors held 2,000 positions worth $1.89B, down 13% from $2.17B the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.

A.R.T. Advisors withdrew a net $295M in Q2 2017, closing 638 positions and reducing 399 holdings. Its most notable exit was Micron Technology, an estimated $14.7M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 11% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, A.R.T. Advisors opened a new position in Broadcom worth $8.79M.

  • A.R.T. Advisors's largest Q2 2017 buy was Broadcom: 377,000 shares worth $8.79M.
  • A.R.T. Advisors added most to Amgen in Q2 2017, an estimated $10.9M increase.
  • A.R.T. Advisors's biggest Q2 2017 reduction was Amazon, cutting an estimated $15.4M.
  • A.R.T. Advisors fully exited Micron Technology in Q2 2017, selling an estimated $14.7M.
  • A.R.T. Advisors's ten largest holdings make up 7.6% of its $1.89B portfolio in Q2 2017.
  • A.R.T. Advisors opened 609 new positions and closed 638 in Q2 2017.
  • A.R.T. Advisors's portfolio value fell 13% quarter-over-quarter to $1.89B.

Based on A.R.T. Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.